Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Marrone Bio Innovations revenue
Marrone Bio Innovations's revenue is $44.3 million.
What is Marrone Bio Innovations's revenue?
- Marrone Bio Innovations's revenue growth from 2012 to 2021 is 520.59%.
- Marrone Bio Innovations has 145 employees, and the revenue per employee ratio is $305,586.
- Marrone Bio Innovations's peak quarterly revenue was $12.6M in 2021(q2).
- Marrone Bio Innovations peak revenue was $44.3M in 2021.
- Marrone Bio Innovations annual revenue for 2020 was 38.4M, 30.64% growth from 2019.
- Marrone Bio Innovations annual revenue for 2021 was 44.3M, 15.47% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Marrone Bio Innovations historical revenue
Marrone Bio Innovations's peak revenue was $44.3M in 2021. The peak quarterly revenue was $12.6M in 2021(q2).
Marrone Bio Innovations's revenue increased from $7.1m in 2012 to $44.3M currently. That's a 520.59% change in annual revenue.
Marrone Bio Innovations annual revenue
Marrone Bio Innovations annual revenue over time
| Fiscal year / year | Marrone Bio Innovations revenue |
|---|---|
| 2012 | $7.1M |
| 2013 | $8.4M |
| 2014 | $9.1M |
| 2015 | $9.8M |
| 2016 | $14.0M |
| 2017 | $18.2M |
| 2018 | $21.2M |
| 2019 | $29.4M |
| 2020 | $38.4M |
| 2021 | $44.3M |
Rate Marrone Bio Innovations' financial transparency
Marrone Bio Innovations annual growth
Marrone Bio Innovations saw the greatest revenue growth in 2016, when revenue increased by 43.27%.
Marrone Bio Innovations had the lowest revenue growth in 2015, when revenue changed by 7.28%.
Marrone Bio Innovations annual growth rate over time
| Year | Marrone Bio Innovations growth |
|---|---|
| 2013 | 18%↑ |
| 2014 | 8%↑ |
| 2015 | 7%↑ |
| 2016 | 43%↑ |
| 2017 | 29%↑ |
| 2018 | 17%↑ |
| 2019 | 38%↑ |
| 2020 | 31%↑ |
| 2021 | 15%↑ |
Marrone Bio Innovations quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Marrone Bio Innovations quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $1.1M |
| 2015 | $2.1M | $3.4M | $2.5M | $1.9M |
| 2016 | $2.7M | $5.0M | $3.6M | $2.7M |
| 2017 | $4.2M | $6.5M | $4.2M | $3.3M |
| 2018 | $4.3M | $5.8M | $5.4M | $5.7M |
| 2019 | $8.7M | $7.0M | $7.0M | $6.7M |
| 2020 | $9.7M | $12.2M | $8.8M | $7.7M |
| 2021 | $11.0M | $12.6M | $9.9M | $10.8M |
| 2022 | $11.1M | - | - | - |
Marrone Bio Innovations jobs nearby
Do you work at Marrone Bio Innovations?
Did Marrone Bio Innovations meet its revenue projections?
Marrone Bio Innovations financial information
| CEO | Kevin R. Helash |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 145 |
| Date Founded | 2006 |
| Headquarters | Davis, California |
| Number of Locations | 2 |
| Revenue | $44.3M |
| Net Income | -$16,554,000 |
| Gross Proft | $27.2M (2021) |
| PE Ratio | -10.15 |
| Tax Rate | -0.0% |
| Market Capitalization | $168.1M |
| Total Assets | $87,056,000 |
| Ticker | MBII |
Marrone Bio Innovations jobs you might like
Marrone Bio Innovations financing
Marrone Bio Innovations received early financing of $3.8M on 2007-05-02.
| Series | Round size | Date |
|---|---|---|
| Series A | $3.8M | 05/2007 |
| Series B | $10M | 08/2008 |
| Series C | $25.4M | 06/2011 |
| Debt Financing | $10M | 04/2012 |
| Post Ipo Equity | $49.2M | 06/2014 |
| Post Ipo Debt | $40M | 08/2015 |
| Post Ipo Equity | $9.2M | 04/2017 |
| Post Ipo Equity | $30M | 02/2018 |
| Post Ipo Equity | $12M | 04/2018 |
Marrone Bio Innovations investors
| Investors | Security type |
|---|---|
| Calvert Social Venture Partners | Series A |
| Saffron Hill Ventures | Series A |
| One Earth Capital | Series A |
| Clean Pacific Ventures | Series A |
| Valley Oak Investments | Series A |
| Wavepoint Ventures | Series A |
| Stuart Mill Venture Partners | Series B |
| Mitsui & Co. Global Investment | Series C |
| Stuart Mill Venture Partners | Series C |
| Saffron Hill Ventures | Series C |
| One Earth Capital | Series C |
| Contrarian Group | Series C |
| Clean Pacific Ventures | Series C |
| Syngenta | Series C |
| Point Financial | Debt Financing |
| Ospraie Ag Sciences | Post Ipo Equity |
Marrone Bio Innovations revenue FAQs
Search for jobs
Marrone Bio Innovations highest paying jobs
Zippia gives an in-depth look into the details of Marrone Bio Innovations, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Marrone Bio Innovations. The employee data is based on information from people who have self-reported their past or current employments at Marrone Bio Innovations. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Marrone Bio Innovations. The data presented on this page does not represent the view of Marrone Bio Innovations and its employees or that of Zippia.
Marrone Bio Innovations may also be known as or be related to MARRONE BIO INNOVATIONS INC, Marrone Bio Innovations, Marrone Bio Innovations Inc, Marrone Bio Innovations Inc. and Marrone Bio Innovations, Inc.